Using exome sequencing and linkage analysis in a 3-generation family with an unique dominant Mycolonus-Dystonia-like syndrome with cardiac arrhythmias we identified a mutation in the CACNA1B gene, coding for neuronal voltage-gated calcium channels Ca V 2.2. This mutation (c.4166G>A;p.Arg1389His) is a disruptive missense mutation in the outer region of the ion pore. The functional consequences of the identified mutation was studied using whole cell and single channel patch recordings. High resolution analyses at the single channel level showed that, when open, R1389H Ca V 2.2 channels carried less current compared to WT channels. Other biophysical channel properties were unaltered in R1389H channels including ion selectivity, voltage-dependent activation or voltage-dependent inactivation. Ca V 2.2 channels regulate transmitter release at inhibitory and excitatory synapses. Functional changes could be consistent with a gain-of-function causing the observed hyperexcitability characteristic of this unique Myoclonus-Dystonia-like syndrome associated with cardiac arrhythmias. by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from
INTRODUCTION
Myoclonus-Dystonia syndrome (M-D, MIM #159900) is a rare hyperkinetic movement disorder with myoclonic symptoms (sudden, shock-like movements) combined with dystonia, mainly of the upper part of the body.(1) Psychiatric comorbidity has been described and symptoms often respond to alcohol ingestion. (2) (3) (4) Up to 50% of individuals with definite M-D have mutations in the epsilonsarcoglycan gene (SGCE, DYT11, MIM159900).(5-7) Previously, we described a SGCE-negative 3generation pedigree with an unique familial M-D syndrome of unknown cause.(8) Affected members of this family (n = 5) suffered from cervical and axial dystonia at rest, writer's cramp and actioninduced foot dystonia. Myoclonic jerks with on EMG semirhythmic bursts of 40-200ms occurred in legs and arms during rest. Additional symptoms, not previously described in M-D, include highfrequency continuous myoclonus in the legs while standing causing unsteadiness. Intermuscular and corticomuscular coherences around 12 Hz were present and the phase differences suggested an afferent (sensory) cortical input. Eye movement recordings suggest cerebellar pathology. Also present and not previously linked to M-D were cardiac arrhythmias and attacks of painful cramps in upper and lower limbs in 3 of 5 affected family members. By combining exome sequencing with linkage mapping in this pedigree we identified three mutations, but focused on a mutation R1389H (rs184841813) in the CACNA1B gene that codes for a presynaptic neuronal voltage-gated calcium channels Ca V 2.2 (MIM 601012). By studying single channel currents of mutant and wild-type human Ca V 2.2 channels in a mammalian cell line, we reveal that the R1389H mutation affects the rate of ion flow through single ion channels. These functional analyses of cloned Ca V 2.2 channels are consistent with a gain-of-function phenotype.
RESULTS

Patients
We used a 3-generation pedigree for our studies, including 5 of 16 family members suffering from an M-D-plus syndrome previously described.(8) (Fig 1) Features compatible with the known M-D phenotype were cervical and axial dystonia at rest, writer's cramp and action-induced foot dystonia with walking, myoclonic jerks in legs and arms, increasing with action, a positive effect of alcohol on No myoclonic jerks or orthostatic myoclonus were noticed. His diagnosis was confirmed by an independent neurologist. This individual was therefore considered unaffected in further study.
CACNA1B R1389H
Linkage analysis assuming a dominant mode of inheritance identified a region of interest of approximately 150 MB. In this region 5 rare heterozygous missense SNVs were found by exome sequencing in affected family member III-2, confirmed by Sanger sequencing. Segregation with disease within the family was seen for three rare SNVs: CACNA1B c.4166G>A:p.R1389H, rs184841813 (NM_000718), VPS13D c.10355A>G:p.Q3452R (NM_015378) and SPTAN1 c.5308C>T:p.R1770C, rs371055930 (NM_001130438). These SNVs were not present in 760 (1012 for CACNA1B) healthy Dutch controls from the Dutch Blood Bank. Both the CACNA1B and SPTAN1
SNVs are present at very low frequencies in the ±6500 exome variant server (EVS, http://evs.gs.washington.edu/EVS/) (EVS MAF 9.2*10 -4 and 7.6*10 -5 respectively). Since M-D is a relatively frequent disorder and EVS participants were not screened for movement disorders, the presence of these variants in EVS is not an argument against their pathogenicity.
The VPS13D Q3452R substitution is predicted to be tolerated (SIFT, PolyPhen) as the amino acid is moderately conserved and there is only a small physiochemical difference between Gln and Arg. The R1770C variant in SPTAN1 and R1389H in CACNA1B are predicted to be deleterious and residues are well conserved among species. The lack of an association of previously found mutations in SPTAN1 to M-D, lead us to focus on the CACNA1B variant. The clinical presentation of myoclonic jerks and dystonia in combination with arrhythmias in this family pointed to a possible channelopathy.
The CACNA1B gene encodes Ca V 2.2, the main of pore-forming alpha-1 subunit of the multi-subunit by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from voltage-gated calcium channel complex that underlies N-type currents in neurons. The preferential location of Ca V 2.2 is at nerve terminals and they play a critical role in controlling transmitter release at many synapses.(9) Previously identified pathogenic CACNA1A mutations in the homologous region of the gene cause familial hemiplegic migraine (V1457L, OMIM 601011.0019)(10) and causing episodic ataxia (type 2) (F1406C, OMIM 601011.0022). (11, 12 ) Ca V 2.2 null mice have a major locomotion phenotype, showing significantly more activity (our work, unpublished, and (13, 14) ).
The region of CACNA1B coding for the IIIS5 through IIIS6 was Sanger sequenced in 47 patients with an M-D phenotype. All contained wild-type R1389 and no other novel missense SNVs were identified.
Given the location of R1389 in the extracellular ion pore loop of S5-S6 in CaV2.2 ( Fig 3A) , we were able to monitor protein function directly.
Functional analyses R1389H hCa V 2.2
To assess the functional consequences of the R1389H mutation on the biophysical properties of Ca V channels we expressed wild-type and mutant hCa V 2.2 channels in the mammalian tsA201 cell line and compared calcium channel currents using whole cell and single channel patch recordings (Fig 2 -4 ).
Peak and instantaneous current voltage relationships illustrate that currents through wild-type and R1389H mutant channels reverse direction at close to the same voltages (54 mV and 52 mV; Fig 2C, 2F). This suggests that R1389H has little or no influence on ion selectivity. Channel properties that reflect gating mechanisms such as the voltage-dependence of activation and inactivation were also not different between wild-type and R1389H channels ( Fig 2D, 2E ). Thus the biophysical properties of whole cell currents were not different, although average whole cell hCa V 2.2 current densities in cells expressing R1389H were larger compared to wild-type (Fig 2A -2C) . The functional significance of such a difference in current densities in a non-neuronal overexpression system is not clear. The clones are expressed at high level and several factors contribute to overall current density that are independent of the biophysical properties of the channel but depend on cell-type and subcellular location, including translation efficiency, plasma membrane trafficking, protein stability.(15) 6 We therefore used high-resolution cell-attached patch recordings to make exact measurements of ion flow through single hCa V 2.2 wild-type and R1389H mutant ion channels (Fig 3, 4 ). Single channel currents of R1389H were smaller on average compared to wild-type measured under identical conditions ( Fig 3B -3D) . At +20 mV, the dominant current amplitude of single wild-type channels was 1.03 ± 0.02 (n = 8 control patch recordings) compared to 0.77 ± 0.01 for R1389H (n = 8 patch recordings; p = 9.1 × 10 -10 , Student's t-test) ( Fig 3B -3D ). Further analysis revealed that human 
DISCUSSION
We report a missense mutation (c.4166 G>A;p.Arg1389His, rs184841813) in the CACNA1B gene in a 3-generation family with a Myoclonus-Dystonia-like syndrome characterized by progressive myoclonic jerks, dystonia and an action-induced lower limb myoclonus combined with cardiac arrhythmias in one pedigree. Clinical and electrophysiological assessment of patients from this family is most consistent with a subcortical origin with possible cerebellar involvement. CACNA1B codes for the pore-forming subunit of presynaptic Ca V 2. After finalizing our studies, the considered unaffected sibling (III-4) presented with a sudden onset, fixed dystonic posture of the left ankle and wrist without myoclonic jerks. His presentation was very different form the affected members and consistent with functional dystonia. We therefore, still consider him unaffected. His clinical diagnosis was confirmed by an independent neurologist. He did not carry the variant and did not share the same haplotype as affected individuals. This twist in the story illustrates the difficulty of family studies in dystonia. Ca V 2.2 forms a complex with Ca V a 2 d and Ca V b subunits that localizes to active zones of presynaptic nerve terminals throughout the brain and nervous system. Together with Ca V 2.1, the activity of Ca V 2.2 controls the amount of transmitter released in response to depolarization of the presynaptic terminal.
At most synapses, the concerted action of Ca V 2.1 and Ca V 2.2 channels regulate depolarizationdependent presynaptic calcium entry, while at other synapses presynaptic Ca V 2.1 or Ca V 2.2 channels control calcium entry exclusively. (9, 16, 17) Our functional analyses reveal reduced rate of ion flow through single ion channels compared to wild-type. Other essential biophysical channel properties were unaltered in R1389H channels including ion selectivity, voltage-dependent activation or voltagedependent inactivation. The activation duration of single R1389H mutant channels tended to be longer on average, compared to WT channels. For example, longer activation times of R1389H compared to WT allowed measurements of channel amplitudes at more negative potentialswhen channel open times are shorterand wild-type controls currents were too short to measure accurately (Fig 3C, 3D) .
A longer activation time at the single channel level could give rise to larger current densities in whole cell recordings of R1389H compared to wild-type controls (Fig 2) . We did observe consistent differences in the overall expression level of Ca V 2.2 channels, but current density measurements depend on several factors that may be influenced by the specific over-expression system used, cell- gain more insight in the pathophysiology of dystonia and hopefully discover promising pharmaceutical therapies for certain forms of (myoclonus) dystonia.
MATERIALS AND METHODS
Patients
All patients were previously described.(8) The study was approved by the Medical Ethical Committee of the Academic Medical Center Amsterdam. All patients were examined by a movement disorder specialist (MAJT). Investigations were performed with informed consent.
We performed linkage analysis in this three generation family and combined these results with the exome data, obtained in the index case.
Linkage analysis
Linkage analysis was performed using the Affymetrix GeneChip Human Mapping 250K Nsp Array in 5 affected and one unaffected sibling from 3 generations The linkage analysis was performed in family members II-2, III-2, III-3, III-4, III-6, IV-6 (see Fig 1) . 
Electrophysiological analyses of human-derived Ca V 2.2 clones
Full-length human Ca V 2.2 cDNA (ORF 7094 bp, pSAD442-1) was cloned from human brain and spinal cord and inserted into pcDNA6 mammalian expression vector. pSAD442-1 contains alternate exons [+e10a, +18a, 19a, +e31a, +e37b, +e46]. (27) The R1389H mutant was generated using standard mutagenesis methods and sequence confirmed. Wild-type and mutant hCa V 2.2 were transiently expressed in human tsA201 cells with Ca V  3 , Ca V  2 -1 and enhanced green fluorescent protein cDNAs (eGFP; BD Bioscience) as described previously.(28) Whole cell and single calcium channel currents were recorded 24 hours after transfection. cDNA concentrations were measured and visualized in agarose gels to ensure these were not different between mutant and wild-type transfections. Recording from wild-type and mutant Ca V 2.2 clones were interspersed and the experimenter blind to clone identity during recording and analysis. Macroscopic, whole cell recordings In individual III-2 exome sequencing was performed. 
Figure 2. Whole cell calcium currents recorded from tsA201 cells transiently expressing human R1389H and wild-type control (WT) Ca
